Security key
00791X209
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 11,898,571
- Total 13F shares
- 1,364,447
- Share change
- +93,230
- Total reported value
- $1,103,333
- Price per share
- $0.81
- Number of holders
- 21
- Value change
- +$78,032
- Number of buys
- 7
- Number of sells
- 5
Report period
Q3 2025
Institutions
21
Top holders
10
AEON full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
AEON Biopharma, Inc. SEC filings
AEON Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00791X209
Recent filing periods:
Top shareholders of AEON - AEON Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Jorey Chernett |
13D/G
|
Chernett Jorey |
9.9%
|
1,128,500
|
$564,250 | $0 | 27 May 2025 | |
| Dauntless Investment Group, LLC |
13F
13D/G
|
Company |
9.7%
from 13D/G
|
1,125,000
|
$475,000 | — | 30 Jun 2025 | |
| BIGGER CAPITAL FUND L P |
13D/G
|
Bigger Michael |
6.1%
|
4,900,000
|
$343,000 | $0 | 06 Jan 2025 | |
| PALMISANO ROBERT J |
13D/G
3/4/5
|
Robert J Palmisano · Director |
5.7%
|
2,265,000
|
$158,550 | $0 | 25 Jul 2024 | |
| L1 Capital Global Opportunities Master Fund, Ltd. |
13D/G
|
— |
4.1%
|
465,029
|
$32,552 | -$594,648 | 31 Mar 2025 | |
| Blue Owl Capital Holdings LP |
13D/G
13F
|
Company |
3.8%
|
3,049,361
|
$213,455 | $0 | 31 Dec 2024 | |
| Alta Partners LLC |
13D/G
|
— |
2.1%
|
249,870
|
$192,400 | -$259,078 | 30 Sep 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.38%
|
45,258
|
$34,000 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.27%
|
31,600
|
$24,016 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
20,695
|
$15,727 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.02%
|
2,855
|
$2,170 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
2,385
|
$1,813 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
272
|
$207 | — | 30 Jun 2025 | |
| DUPONT CAPITAL MANAGEMENT CORP |
13F
|
Company |
0%
|
170
|
$129 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
150
|
$114 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
106
|
$81 | — | 30 Jun 2025 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
100
|
$76 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
90
|
$68 | — | 30 Jun 2025 | |
| WOLFF WIESE MAGANA LLC |
13F
|
Company |
0%
|
67
|
$51 | — | 30 Jun 2025 | |
| MAI Capital Management |
13F
|
Company |
0%
|
58
|
$45 | — | 30 Jun 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0%
|
33
|
$25 | — | 30 Jun 2025 | |
| GHP Investment Advisors, Inc. |
13F
|
Company |
0%
|
24
|
$19 | — | 30 Jun 2025 | |
| DANSKE BANK A/S |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Jun 2025 | |
| Priveterra Sponsor, LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
14,013,205
mixed-class rows
|
$138,891,630 | — | 21 Jul 2023 | |
| Strathspey Crown Holdings Group, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,031,773
|
$20,317,730 | — | 11 Aug 2023 | |
| BARCLAYS PLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
702,645
|
— | — | 20 Feb 2023 | |
| Jost Fischer |
3/4/5
|
Director |
—
mixed-class rows
|
671,636
mixed-class rows
|
$130,057 | — | 21 May 2025 | |
| Marc Forth |
3/4/5
|
Director |
—
mixed-class rows
|
2,376,979
mixed-class rows
|
— | — | 21 May 2025 | |
| Eric G. Carter |
3/4/5
|
Director |
—
mixed-class rows
|
440,872
mixed-class rows
|
— | — | 21 May 2025 | |
| Shelley B. Thunen |
3/4/5
|
Director |
—
mixed-class rows
|
440,872
mixed-class rows
|
— | — | 21 May 2025 |
Institutional Holders of AEON Biopharma, Inc. - Common Stock (AEON) as of Q3 2025
As of 30 Sep 2025,
AEON Biopharma, Inc. - Common Stock (AEON) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,364,447 shares.
The largest 10 holders included
Dauntless Investment Group, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Blue Owl Capital Holdings LP, StoneX Group Inc., XTX Topco Ltd, JANE STREET GROUP, LLC, BlackRock, Inc., BANK OF AMERICA CORP /DE/, and UBS Group AG.
This page lists
21
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
18
Q3 2025 holders
21
Holder diff
3
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.